← Leaderboards
Guillaume Lettre
Massachusetts General Hospital
$1,695,259
Attributed
$6,781,035
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$6,781,035 · 1
By mechanism
UM1$6,781,035 · 1
Top collaborators
- Daniel Evan Bauer4 shared
- Luca Pinello4 shared
- Richard I Sherwood4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Gina Marie Peloso$4,459,562
- Shengdar Tsai$7,312,012
- Jose Carlos Florez$39,251,920
- Jonathan Rosand$24,467,190
- Maha Farhat$7,486,819
Others in their field
Other Emerging Leaders on “Crispr Interference”
- Jesse M Engreitz · Stanford University$9,148,881
- David R Raleigh · University Of California, San Francisco$6,991,237
- Chongyuan Luo · University Of California Los Angeles$5,719,197
- Xingyi Guo · Vanderbilt University Medical Center$4,610,997
- Jeremy Michael Rock · Rockefeller University$4,606,998
- Kyle Jeffrie Gaulton · University Of California, San Diego$4,359,345
Research focus
Crispr InterferenceCrispr ScreenBiologicalCrispr/Cas TechnologyBlood CellsBlood LipidBlood PlateletsBlood PressureBloodCardiovascular SystemCatalogsCausal VariantCell LineCell PhysiologyCellsCellular AssayChromatinClustered Regularly Interspaced Short Palindromic RepeatsCardiovascular DiseasesCommunitiesComputational PipelinesComputing MethodologiesCoronary ArteriosclerosisData Collection
Grant awards (4)
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,890,246
UM1 · FY2024 · HG
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,928,820
UM1 · FY2023 · HG
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,928,820
UM1 · FY2022 · HG
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,033,149
UM1 · FY2021 · HG